Natera Raises $54.6M to Support Expansion of Panorama Test | GenomeWeb

NEW YORK (GenomeWeb News) – Noninvasive prenatal test developer Natera has completed a $54.6 million financing round to support its expansion and the rollout of its sequencing-based fetal aneuploidy test called Panorama.

Two new investors, OrbiMed Advisors and Harmony Partners, and other new undisclosed investors joined the company's existing investors, Claremont Creek Ventures, Lightspeed Venture Partners, Founders Fund, and Sequoia Capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.